Hu S, Gao B, Li Z, Yuan Y
Oncol Lett. 2024; 28(6):595.
PMID: 39430730
PMC: 11487496.
DOI: 10.3892/ol.2024.14728.
Mishra A, Oberoi A, Deo S, Sharma J, Gogia A, Sharma D
Indian J Surg Oncol. 2023; 14(3):651-658.
PMID: 37900630
PMC: 10611650.
DOI: 10.1007/s13193-023-01731-x.
Mallory M, Whiting K, Park A, Gonen M, Gilbert E, King T
Breast Cancer Res Treat. 2022; 194(1):137-148.
PMID: 35488092
PMC: 11325477.
DOI: 10.1007/s10549-022-06532-4.
Brown Z, Schellenberg A, Cordeiro E, Holloway C, Scheer A, Eisen A
Can J Surg. 2022; 65(2):E250-E256.
PMID: 35365498
PMC: 8979655.
DOI: 10.1503/cjs.003420.
Shinden Y, Saho H, Nomoto Y, Nagata A, Minami K, Nakajo A
Surg Case Rep. 2020; 6(1):215.
PMID: 32833091
PMC: 7445210.
DOI: 10.1186/s40792-020-00966-y.
Whole Exome Sequencing in the Accurate Diagnosis of Bilateral Breast Cancer: a Case Study.
Li X, Yang M, Zhang Q, Fan Y, Zhu T, Chen F
J Breast Cancer. 2019; 22(1):131-140.
PMID: 30941240
PMC: 6438836.
DOI: 10.4048/jbc.2019.22.e10.
HER2 positive bilateral metachronous primary breast carcinoma: A case report.
Yao J, Liu J, Li Y, Li Y, Wu Q, Yang Y
Cancer Biol Ther. 2018; 19(5):349-354.
PMID: 29333901
PMC: 5915025.
DOI: 10.1080/15384047.2018.1423916.
Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance.
See M, Bhoo-Pathy N, Jamaris S, Kiran A, Evans D, Yip C
World J Surg. 2017; 42(5):1270-1277.
PMID: 29124356
DOI: 10.1007/s00268-017-4319-6.
Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
Davies K, Brewster A, Bedrosian I, Parker P, Crosby M, Peterson S
Breast Cancer Res. 2016; 18(1):93.
PMID: 27650678
PMC: 5028980.
DOI: 10.1186/s13058-016-0752-y.
Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.
Parker P, Peterson S, Bedrosian I, Crosby M, Shen Y, Black D
Ann Surg. 2015; 263(1):178-83.
PMID: 25822675
PMC: 4973510.
DOI: 10.1097/SLA.0000000000001216.
Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy.
Davies K, Cantor S, Brewster A
Int J Womens Health. 2015; 7:181-7.
PMID: 25678823
PMC: 4324540.
DOI: 10.2147/IJWH.S52380.
Role of preoperative magnetic resonance imaging in the surgical management of early-stage breast cancer.
Chandwani S, George P, Azu M, Bandera E, Ambrosone C, Rhoads G
Ann Surg Oncol. 2014; 21(11):3473-80.
PMID: 24912611
PMC: 4440653.
DOI: 10.1245/s10434-014-3748-9.
Change of mammographic density predicts the risk of contralateral breast cancer--a case-control study.
Sandberg M, Li J, Hall P, Hartman M, Dos-Santos-Silva I, Humphreys K
Breast Cancer Res. 2013; 15(4):R57.
PMID: 23876209
PMC: 3978478.
DOI: 10.1186/bcr3451.
Occult breast tumor reservoir: biological properties and clinical significance.
Santen R, Yue W, Heitjan D
Horm Cancer. 2013; 4(4):195-207.
PMID: 23632998
PMC: 10358155.
DOI: 10.1007/s12672-013-0145-y.
Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study.
Sandberg M, Hall P, Hartman M, Johansson A, Eloranta S, Ploner A
PLoS One. 2012; 7(10):e46535.
PMID: 23056335
PMC: 3466301.
DOI: 10.1371/journal.pone.0046535.
Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy.
Santen R, Yue W, Heitjan D
Cancer Epidemiol Biomarkers Prev. 2012; 21(7):1038-48.
PMID: 22586072
PMC: 4589189.
DOI: 10.1158/1055-9965.EPI-12-0043.
Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.
Brewster A, Bedrosian I, Parker P, Dong W, Peterson S, Cantor S
Cancer. 2012; 118(22):5637-43.
PMID: 22517269
PMC: 3478501.
DOI: 10.1002/cncr.27574.
Incidental breast cancers identified in the one-stop symptomatic breast clinic.
Mehrotra P, Townend A, Lunt L
J Breast Cancer. 2011; 14(1):28-32.
PMID: 21847391
PMC: 3148519.
DOI: 10.4048/jbc.2011.14.1.28.
Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer.
Brewster A, Parker P
Oncologist. 2011; 16(7):935-41.
PMID: 21672945
PMC: 3228146.
DOI: 10.1634/theoncologist.2011-0022.
Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
Yi M, Hunt K, Arun B, Bedrosian I, Gutierrez Barrera A, Do K
Cancer Prev Res (Phila). 2010; 3(8):1026-34.
PMID: 20647335
PMC: 4340054.
DOI: 10.1158/1940-6207.CAPR-09-0130.
